Arbutus Biopharma
700 Veterans Circle
Warminster
PA
18974
United States
Tel: 267-469-0914
Website: http://www.arbutusbio.com/
Email: ir@arbutusbio.com
462 articles about Arbutus Biopharma
-
Tekmira Pharmaceuticals Corporation Provides Periodic Update to Litigation
10/20/2011
-
Tekmira Pharmaceuticals Corporation and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus
9/12/2011
-
Tekmira Pharmaceuticals Corporation to Present at the Stifel Nicolaus Annual Healthcare Conference
9/1/2011
-
Tekmira Pharmaceuticals Corporation Acquires Worldwide Exclusive License to Novel RNAi Platform
8/25/2011
-
Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces Second Quarter 2011 Results
8/11/2011
-
Tekmira Pharmaceuticals Corporation Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute
8/9/2011
-
Tekmira Pharmaceuticals Corporation Conference Call and Webcast Advisory: Second Quarter 2011 Operating Results and Corporate Update
8/4/2011
-
Tekmira Pharmaceuticals Corporation Reports Expected Answer and Amended Counterclaim is Filed by Alnylam Pharmaceuticals
6/29/2011
-
Tekmira Pharmaceuticals Corporation Closes $5.1 Million Public Offering
6/16/2011
-
Tekmira Pharmaceuticals Corporation Prices Public Offering; Expects $5 Million
6/9/2011
-
Tekmira Pharmaceuticals Corporation Prices Public Offering
6/9/2011
-
Tekmira Pharmaceuticals Corporation's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity
6/6/2011
-
Tekmira Pharmaceuticals Corporation Files Amended Complaint in Alnylam Pharmaceuticals Litigation
6/6/2011
-
Tekmira Pharmaceuticals Corporation Expands Oncology Pipeline With RNAi Therapeutic Targeting Novel Cancer Genes WEE1 and CSN5
6/2/2011
-
Tekmira Pharmaceuticals Corporation Presents LNP Technology Innovations at Scientific Symposium
5/27/2011
-
Tekmira Pharmaceuticals Corporation to Present at the ThinkEquity 2nd Annual Healthcare Conference
5/20/2011
-
Bristol-Myers Squibb Company Expands Deal to Evaluate Tekmira Pharmaceuticals Corporation’s RNAi Delivery Technology
5/17/2011
-
Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces First Quarter 2011 Results
5/11/2011
-
Tekmira Pharmaceuticals Corporation Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update
5/4/2011
-
Tekmira Pharmaceuticals Corporation and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target
4/21/2011